Prostate cancer molecular detection in plasma samples by glutathione S-transferase P1 (GSTP1) methylation analysis

Clinical Laboratory

Volumn 60, Issue 5, 2014, Pages 847-852

  Dumache, Raluca ^a   Puiu, Maria ^a   Motoc, Marilena ^a   Vernic, Corina ^a   Dumitrascu, Victor ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Benign prostatic hyperplasia (BPH); Glutathione s transferase p1 (GSTP1); Methylation specific polymerase chain reaction (MS PCR); Prostate cancer (PCa)

Indexed keywords

BISULFITE; DNA; GENOMIC DNA; GLUTATHIONE TRANSFERASE P1;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DNA EXTRACTION; DNA ISOLATION; DNA METHYLATION; ENZYME BLOOD LEVEL; GLEASON SCORE; HUMAN; HUMAN TISSUE; MALE; METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; MINIMALLY INVASIVE PROCEDURE; MOLECULAR DIAGNOSIS; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROSTATE CANCER; PROSTATE HYPERTROPHY; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION;

ADULT; AGED; CASE-CONTROL STUDIES; DNA METHYLATION; GLUTATHIONE S-TRANSFERASE PI; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84899886835     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2013.130701     Document Type: Article

References (11)

1. Siegel R, Naishhadham D, Jemal A. Cancer statistics. CA Cancer J Clin 2012;62:10-29.
2. Greene KL, Albertsten PC, Babaian RJ, et al.Prostate specific antigen best practice statement: 2009 update. J Urol 2009; 182:2232-41.
3. De Marzo AM, Platz EA, Sutcliffe S, et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007;7(4):256-69. (Pubitemid 46486616)
4. Garcia M, Jemal A, Ward EM, et al. Global Cancer Facts & Figures 2007. Atlanta, (GA): American Cancer Society 2007;1-50.
5. Schulz WA, Hoffmann MJ. Epigenetic mechanisms in the biology of prostate cancer. Semin Cancer Biol 2009;19(3):172-80.
6. Henrique R, Jeronimo C, Teixeira MR, et al. Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis. Mol Cancer Res 2006;4(1):1-8. (Pubitemid 43259884)
7. th ed. New York, Springer 2010;457-69.
8. Lasko TA, Bhagwat JG, Zou KH, Ohno-Machado L. The use of receiver operating characteristic curves in biomedical informatics. J Biomed Inform 2005;38:404-15. (Pubitemid 41405811)
9. Ellinger J, Muller SC, Stadler TC, et al. The role of cell-free circulating DNA in the diagnosis and prognosis of prostate cancer. Urol Oncol 2011;29(2):124-9.
10. De Marzo AM, DeWeese TL, Platz EA, et al. Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention and treatment. J Cell Biochem 2004;91:459-77.
11. Henrique R, Jeronimo C, Hoque M, et al. MT1G hypermethylation is associated with higher tumor stage in prostate cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1274-8. (Pubitemid 40656480)